Chemoinformaics analysis of 2,6-Dimethylcyclohexanone
| Molecular Weight | 126.199 | nRot | 0 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 7 |
| Exact Molecular Weight | 126.104 | nRing | 1 |
| Solubility: LogS | -0.915 | nHRing | 0 |
| Solubility: LogP | 1.669 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 23.4971 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.485 |
| Synth | 3.255 |
| Natural Product Likeliness | 0.968 |
| NR-PPAR-gamma | 0.074 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.324 |
| MDCK | 0.0000182 |
| BBB | 0.99 |
| PPB | 0.787871 |
| VDSS | 1.517 |
| FU | 0.296058 |
| CYP1A2-inh | 0.331 |
| CYP1A2-sub | 0.872 |
| CYP2c19-inh | 0.082 |
| CYP2c19-sub | 0.826 |
| CYP2c9-inh | 0.032 |
| CYP2c9-sub | 0.585 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.724 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.322 |
| CL | 11.964 |
| T12 | 0.813 |
| hERG | 0.027 |
| Ames | 0.056 |
| ROA | 0.448 |
| SkinSen | 0.391 |
| Carcinogencity | 0.46 |
| EI | 0.983 |
| Respiratory | 0.32 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.957439 |